Endoscopic ultrasonography-guided pancreaticoduodenostomy with a lumen-apposing metal stent to treat main pancreatic duct dilatation

Kuwatani, Masaki; Nagai, Kosuke; Takishin, Yunosuke; Furukawa, Ryutaro; Hirata, Hajime; Kawakubo, Kazumichi; Sakamoto, Naoya

doi:10.1055/a-1408-0148

Cited by 2 publications

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Alternatively, EUS-guided drainage can be performed with the aid of a LAMS. So far, only one individual case report has been published (50), though the respective article concerns the drainage of a pancreatic fluid collection adjacent to the pancreatic duct rather than a dilated pancreatic duct itself.…”

Section: Alternative Accessmentioning

confidence: 99%

Stent placement in pancreatic disease, when, which and why? – a current perspective

Conrad¹,

Ellrichmann²

2023

Front. Gastroenterol.

View full text Add to dashboard Cite

IntroductionStenting of the pancreas is a challenging task for the interventional gastroenterologist. The indications for pancreatic stent implantation are either prophylactic or therapeutic. We give an overview of currently available literature and techniques for the respective indications of pancreatic stent placement.MethodsA structured literature research was conducted (Pubmed.gov) primarily using the following key words: interventional endoscopy, pancreatic stenting, post-ERCP pancreatitis, pancreatic Q8 fistulae, pancreas divisum.ResultsProphylactic stent implantation aims to prevent PEP by using thin (3-5 Fr) and short (3-5 cm) designated pancreatic stents at least in high-risk patients. Therapeutic stent placement is intended to restore the proper flow of pancreatic secretion with stenoses, leaks, fistulas or anatomical malformation of the pancreatic duct. Depending on the etiology, plastic stents or SEMSs are used. Another field of pancreatic stenting represents EUS-guided puncture with stent implantation as an alternative access to the main pancreatic duct when transpapillary access is impossible. In addition to the implantation of plastic stents, which achieve good results, LAMS implantation can be discussed as an alternative access route.DiscussionThe field of pancreatic stenting is complex and belongs in the hands of experienced endoscopists in specialized institutions. This can ensure that the patient receives the optimal treatment with the best possible outcome.

show abstract

Section: Alternative Accessmentioning

confidence: 99%

Stent placement in pancreatic disease, when, which and why? – a current perspective

Conrad¹,

Ellrichmann²

2023

Front. Gastroenterol.

View full text Add to dashboard Cite

show abstract

“…The emergence of EUS-guided fine needle aspiration cytology was a watershed event in the evolution of EUS, which then ceased to be exclusively a diagnostic procedure. [1][2][3][4][5][6] The era of interventional EUS began with EUS-guided celiac plexus block 1 and today extends to several advanced procedures, mainly for biopsy, 7,8 as well as for the drainage of pancreatic fluid collections and the biliary tract. [9][10][11][12] However, EUS-guided drainage carries a considerable risk of adverse events (AEs), which occur in approximately 23% of the procedures performed for the drainage of pancreatic fluid collections and 2.5-37.0% of those performed for drainage of the biliary tract.…”

Section: Introductionmentioning

confidence: 99%

Managing adverse events after endoscopic ultrasound‐guided drainage of the biliary tract and pancreatic fluid collections: Narrative review (with video)

Funari

Ribeiro

Santos

et al. 2021

Digestive Endoscopy

View full text Add to dashboard Cite

Endoscopic ultrasound (EUS)-guided therapeutic procedures have become increasingly common in clinical practice. The development of EUS-guided fine needle aspiration cytology led to the concept of interventional EUS. However, it carries a considerable risk of adverse events (AEs), which occur in approximately 23% of the procedures performed for the drainage of pancreatic fluid collections and 2.5-37.0% of those performed for drainage of the biliary tract. Although the vast majority of AEs occurring after EUSguided drainage are mild, a deep understanding of such events is necessary for their appropriate management. Because EUS-guided drainage is a novel procedure, there have been few studies of the topic. To our knowledge, this is the first narrative review that focuses on the management and resolution of AEs occurring after EUS-guided drainage of pancreatic fluid collections or the biliary tract. We also include an explanatory video.

show abstract

Endoscopic ultrasonography-guided pancreaticoduodenostomy with a lumen-apposing metal stent to treat main pancreatic duct dilatation

Cited by 2 publications

References 3 publications

Stent placement in pancreatic disease, when, which and why? – a current perspective

Stent placement in pancreatic disease, when, which and why? – a current perspective

Managing adverse events after endoscopic ultrasound‐guided drainage of the biliary tract and pancreatic fluid collections: Narrative review (with video)

Contact Info

Product

Resources

About